Primary |
Parenteral Nutrition |
75.0% |
Nutritional Support |
12.5% |
Pancreatitis |
12.5% |
|
Hepatic Failure |
62.5% |
Bacteraemia |
12.5% |
Neonatal Tachycardia |
12.5% |
Wheezing |
12.5% |
|
Secondary |
Drug Therapy |
16.8% |
Nutritional Support |
12.0% |
Pain |
8.4% |
Cardiac Failure |
6.8% |
Intraoperative Care |
6.4% |
Infection |
6.0% |
Coronary Artery Disease |
4.0% |
Drug Use For Unknown Indication |
4.0% |
Parenteral Nutrition |
4.0% |
Inflammation |
3.6% |
Exophthalmos |
3.2% |
Gastrointestinal Disorder Therapy |
3.2% |
Prophylaxis Against Gastrointestinal Ulcer |
3.2% |
Restlessness |
3.2% |
Secretion Discharge |
3.2% |
Short-bowel Syndrome |
3.2% |
Candidiasis |
2.4% |
Fluid Replacement |
2.4% |
Cardiovascular Disorder |
2.0% |
Diabetes Mellitus |
2.0% |
|
Thermal Burn |
22.7% |
Toxic Epidermal Necrolysis |
18.2% |
Death |
9.1% |
Drug-induced Liver Injury |
9.1% |
Adrenal Suppression |
4.5% |
Blood Phosphorus Decreased |
4.5% |
Diarrhoea |
4.5% |
Erythema |
4.5% |
Hyperhidrosis |
4.5% |
Local Swelling |
4.5% |
Lung Disorder |
4.5% |
Pyrexia |
4.5% |
Wrong Technique In Drug Usage Process |
4.5% |
|
Concomitant |
Product Used For Unknown Indication |
36.2% |
Drug Use For Unknown Indication |
14.4% |
Prophylaxis |
11.0% |
Constipation |
5.3% |
Cancer Pain |
4.2% |
Pain |
3.0% |
Hypertension |
2.9% |
Nutritional Support |
2.5% |
Nausea |
2.4% |
Pneumonia |
2.1% |
Ovarian Cancer Recurrent |
1.9% |
Crohn's Disease |
1.8% |
Deep Vein Thrombosis |
1.8% |
Psoriatic Arthropathy |
1.8% |
Intestinal Obstruction |
1.7% |
Insomnia |
1.6% |
Pyrexia |
1.5% |
Psoas Abscess |
1.2% |
Stomatitis |
1.2% |
Dehydration |
1.2% |
|
Intestinal Obstruction |
11.3% |
Leukopenia |
9.3% |
Anaemia |
7.3% |
Pyrexia |
7.3% |
Urinary Tract Infection |
6.6% |
Vomiting |
6.6% |
Thrombocytopenia |
6.0% |
Renal Failure Acute |
5.3% |
Stevens-johnson Syndrome |
5.3% |
Liver Disorder |
4.0% |
Pneumonia |
4.0% |
Pneumonia Aspiration |
4.0% |
Respiratory Failure |
4.0% |
Stomatitis |
3.3% |
Weight Decreased |
3.3% |
Haematochezia |
2.6% |
Histiocytosis Haematophagic |
2.6% |
Toxic Epidermal Necrolysis |
2.6% |
Wound Dehiscence |
2.6% |
Anaphylactic Reaction |
2.0% |
|